Unexpectedly, the SNP34091C variant is associated with increased risk of breast cancer, high-grade ovarian cancer (HGSOC), and prostate cancer suggesting a specific sensitivity of these hormone-dependent cancers to presumably low MDM4 levels (79, 84). This evidence concerns the gene MDM4 and breast carcinoma.